【24h】

SNPs for Sale. Cheap!

机译:待售SNP。贱!

获取原文
获取外文期刊封面目录资料

摘要

The development of technically simple and reliable methods to detect sequence variations in specific genes is becoming more important as the number of genes associated with specific diseases grows. DNA sequencing is considered the “gold standard” for characterization of specific nucleotide alteration(s) that lead to genetic disease. Although sequencing was long considered too cumbersome, expensive, and operator-dependent for use in the clinical laboratory, a combination of clinical need and improved technology has brought automated DNA sequencing into routine clinical use. Sequencing technology is now firmly entrenched in the clinical molecular diagnostics laboratory, but it remains too expensive and time-consuming for all of the laboratory’s mutation-detection needs. Several PCR-based mutation-detection strategies can be used to identify both characterized and uncharacterized mutations and sequence variations.The degree of allelic heterogeneity, or the number of different disease-causing mutations in a single gene, influences the method used for mutation detection. For diseases that exhibit no or limited heterogeneity (such as sickle cell anemia or factor V Leiden), assay systems designed to detect specific mutations are appropriate. These types of strategies are also appropriate for disorders in which allelic heterogeneity is high but only a limited set of mutations are typically analyzed, such as cystic fibrosis. For disorders in which the mutational spectrum is wide (e.g., mismatch-repair genes in hereditary nonpolyposis colon cancer), a scanning method is needed. A scanning method is also appropriate for analysis of newly identified disease genes for which there is little or no information regarding the number of disease-causing mutations.A wide array of methods and technologies have been proposed for detection of specific mutations, and many of them are in use in clinical and research laboratories worldwide. Examples of the various technologies for specific-mutation analysis include restriction enzyme digestion of PCR-amplified DNA, with or without the introduction of differential …
机译:随着与特定疾病相关的基因数量的增长,开发用于检测特定基因序列变异的技术简单可靠的方法变得越来越重要。 DNA测序被认为是表征导致遗传疾病的特定核苷酸改变的“金标准”。尽管长期以来人们认为测序在临床实验室中使用起来过于繁琐,昂贵且依赖操作员,但结合临床需求和改进的技术,DNA自动测序已进入常规临床应用。现在,测序技术已在临床分子诊断实验室中牢固树立了根基,但对于实验室的所有突变检测需求而言,它仍然过于昂贵且耗时。可以使用几种基于PCR的突变检测策略来鉴定特征性突变和未表征的突变以及序列变异。等位基因异质性的程度或单个基因中不同致病突变的数量会影响用于突变检测的方法。对于没有异质性或异质性有限的疾病(例如镰状细胞性贫血或V因子Leiden),设计用于检测特定突变的分析系统是合适的。这些类型的策略也适用于等位基因异质性很高但通常仅分析有限一组突变的疾病,例如囊性纤维化。对于突变谱较宽的疾病(例如,遗传性非息肉病结肠癌中的错配修复基因),需要一种扫描方法。扫描方法也适用于分析新发现的疾病基因,这些疾病基因很少或根本没有有关致病突变的信息。已经提出了多种检测特定突变的方法和技术,其中很多全世界的临床和研究实验室都在使用它。特异性突变分析的各种技术实例包括PCR扩增的DNA的限制性内切酶消化,无论是否引入差异……

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号